President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how
Trump signed an executive order that will reclassify marijuana as a less harmful drug. The order is aimed at making it easier to research the drug.
President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.
U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here's a look at what that would mean for people shopping at dispensarie
U.S. President Donald Trump on Thursday said he would sign an order recommending the loosening of federal regulations on marijuana, a move that could further reverse decades of tough-on-weed policy.
Shares of Tilray Brands and other cannabis stocks are rising ahead of President Donald Trump's executive order signing ceremony.
U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions on research that could lead to new medical marijuana products. Here is
Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana.
U.S. President Donald Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis, NBC News reported on Tuesday, citing four people with di
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) announced that it has agreed to acquire MTL Cannabis (CSE:MTLC) in a transaction valued at approximately C$125 million on a fully diluted equity basis an
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) announced that it has agreed to acquire MTL Cannabis (CSE:MTLC) in a transaction valued at approximately...
Canadian cannabis stocks remain in focus this week as sector sentiment continues improving. Several Canadian operators maintain meaningful exposure to the U.S. market through brands and partnerships.
President Donald Trump said he is considering an executive order to reclassify marijuana as Schedule III drug, citing research benefits and public demand for policy reform.
Canopy Growth Corporation (CGC) concluded the recent trading session at $1.66, signifying a -4.6% move from its prior day's close.
President Donald Trump told reporters on Monday he is weighing an executive order to reclassify marijuana as a Schedule III substance.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE